Pharmacogenetics and personalized medicine. Are expectations being met?

被引：0
|
作者：
Gervasini, Guillermo [1 ]
机构：
[1] Univ Extremadura, Fac Med, Dept Terapeut Medicoquirurg, Badajoz, Spain
来源：
MEDICINA CLINICA | 2019年 / 152卷 / 09期
关键词：
TAMOXIFEN; CYP2D6;
D O I：
10.1016/j.medcli.2018.12.001
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：368 / 371
页数：4
相关论文
共 25 条
  • [1] Breast cancer pharmacogenetics in the era of personalized medicine
    Yao S.
    Maghsoudlou D.
    Ambrosone C.B.
    Current Breast Cancer Reports, 2012, 4 (4) : 271 - 281
  • [2] CYP2D6 pharmacogenetics and phenoconversion in personalized medicine
    Nahid, Noor A. A.
    Johnson, Julie A. A.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2022, 18 (11) : 769 - 785
  • [3] Expectations, validity, and reality in pharmacogenetics
    Limdi, Nita A.
    Veenstra, David L.
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2010, 63 (09) : 960 - 969
  • [4] Are constitutional pharmacogenetics the missing link in personalized methodology in oncology?
    Ciccolini, Joseph
    BULLETIN DU CANCER, 2012, 99 (10) : 903 - 905
  • [5] Is personalized medicine a dream or a reality?
    Morse, Bridget L.
    Kim, Richard B.
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2015, 52 (01) : 1 - 11
  • [6] Personalized medicine: is it a pharmacogenetic mirage?
    Shah, Rashmi R.
    Shah, Devron R.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 74 (04) : 698 - 721
  • [7] Personalized medicine: a personal view
    Narod, S. A.
    CURRENT ONCOLOGY, 2010, 17 (05) : 217 - 218
  • [8] THE ROLE OF GENETIC INFORMATION IN PERSONALIZED MEDICINE
    Gamma, Alex
    PERSPECTIVES IN BIOLOGY AND MEDICINE, 2013, 56 (04) : 485 - 512
  • [9] Personalized participatory medicine: sharing knowledge and uncertainty
    Gurwitz, David
    Lunshof, Jeantine E.
    GENOME MEDICINE, 2011, 3
  • [10] Personalized participatory medicine: sharing knowledge and uncertainty
    David Gurwitz
    Jeantine E Lunshof
    Genome Medicine, 3
123